2003;108:1809 14. 85. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733 42. 86. Nielsen PH, Terkelsen CJ, Nielsen TT, et al. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myo- cardial Infarction-2 [DANAMI-2] trial). Am J Cardiol. 2011;108:776 81. 87. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) ev- erything? Am J Cardiol. 2003;92:824 6. 88. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfu- sion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019 25. 89. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996; 348:771 5. 90. Chareonthaitawee P, Gibbons RJ, Roberts RS, et al; for the CORE in- vestigators (Collaborative Organisation for RheothRx Evaluation). The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. Heart. 2000;84:142 8. 91. McNamara RL, Herrin J, Wang Y, et al. Impact of delay in door-to-nee- dle time on mortality in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2007;100:1227 32. 92. Milavetz JJ, Giebel DW, Christian TF, et al. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol. 1998;31:1246 51. 93. Newby LK, Rutsch WR, Califf RM, et al; GUSTO-1 Investigators. Time from symptom onset to treatment and outcomes after thrombolytic ther- apy. J Am Coll Cardiol. 1996;27:1646 55. 94. Sch mig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA. 2005;293:2865 72. 95. Gierlotka M, Gasior M, Wilczek K, et al. 